Flu experts say a new flu drug with the ability to kill deadly strains of bird flu promises to provide a much needed third option should a pandemic occur.The antiviral agent Peramivir may well offer a vital new line of defence against the deadly the H5N1 avian strain which had killed 153 people since 2003 and infected 258 others.Peramivir could totally transform global preparations for an influenza pandemic as it has been seen in studies to be more powerful and easier to deliver than eith...Tuesday, 28-Nov-2006 / [ Details... ]
Target Corporation on Monday announced it will expand a discounted generic drug program to all pharmacies, Reuters/New York Times reports. The Minneapolis-based company said all of its 1,287 pharmacies now ...Thursday, 23-Nov-2006 / [ Details... ]
The generic prescription drug discount program introduced earlier this year by Wal-Mart Stores indicates that "markets are, in fact, capable of providing medicines at affordable prices," Peter Pitts, director of the Center for Medicine in the Public Interest and a f...Thursday, 23-Nov-2006 / [ Details... ]
The traditional role of pharmacists is to manufacture and supply medicines. More recently, pharmacists have been faced with increasing health demands: an ever-growing and complex range of medicines, and poor adherence to prescribed medicines, have forced the evolution of the pharmacist's role into a more patient centred approach (known as pharmaceutical care). Adherence to long-term therapy for chronic conditions in developed countries averages 50%, with even lower rates for developing countries....Thursday, 23-Nov-2006 / [ Details... ]
The U.S. Court of Appeals for the District of Columbia on Tuesday vacated an earlier decision that would have provided terminally ill patients with expanded access to experimental medications and likely will rehear the case next summer, Dow Jones/Wall Street Journal reports (Wilde Mathews, Dow Jones/Wall Street Journal, 11/21).In the case, the Abigail Alliance for Better Access to Developmental Drugs and th...Thursday, 23-Nov-2006 / [ Details... ]
American soldiers critically wounded in Iraq are being treated with a potent, experimental, blood-coagulating drug despite evidence it can cause clots in the lungs, heart and brain, leading to strokes, heart attacks and death.The drug, Recombinant Activated Factor VII, was originally designed to treat rare forms of hemophilia and costs $6,000 a dose.Late last year the Food and Drug Administration (FDA) issued a warning that patients who given...Monday, 20-Nov-2006 / [ Details... ]
A furore has erupted in Britain over a decision by the National Institute for Clinical Excellence (NICE), not to recommend the use of an Alzheimer's drug for newly diagnosed patients.The issue involves four drugs, the most popular of which is being Aricept, (donepezil), which is made by Eisai and Pfizer.Though the drugs do not represent a cure, they can significantly alleviate a patient's suffering and slow down the progress of the illne...Monday, 20-Nov-2006 / [ Details... ]
The U.S. Food and Drug Administration (FDA) has expanded the approved use of Herceptin, a biological cancer drug. The new indication is for Herceptin, in combination with other cancer drugs, for the treatment of HER2 positive breast cancer after surgery (lumpectomy or mastectomy). FDA granted priority review to the supplemental application for Herceptin. Herceptin is a targeted therapy against the HER2 protein on cancer cells. When an excess...Sunday, 19-Nov-2006 / [ Details... ]
Despite the fact that the World Trade Organisation (WTO) granted a special exemption five years ago, in order that poor countries could access life-saving drug, poor people in developing countries are still dying needlessly because global pharmaceutical giants continue to monopolise drugs for diseases such as cancer and AIDS.The declaration by the WTO in 2001 intended that rich countries should put patients before profits via its Trade Related Aspe...Wednesday, 15-Nov-2006 / [ Details... ]
The World Health Organization (WHO) and more than 20 international partners are today launching a comprehensive package of measures to help national authorities safeguard their populations from the dangers of counterfeit medicines.At the opening of the first official meeting of IMPACT (the International Medical Products Anti-Counterfeiting Taskforce) in Bonn, WHO and its partners are unveiling a programme covering legislation, law enforcement, regul...Wednesday, 15-Nov-2006 / [ Details... ]
...Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 Next...
Total: 1467